Intellectual Property Law

HB Ad Slot
HB Mobile Ad Slot

Intellectual property applies to many different areas of the legal world. Applying for patents for work-products, by individual employees, trademark laws, copyrights, and how companies leverage their IP asset-rights over employees, are just a few of the many areas the National Law Review covers as it pertains to IP.

Intellectual Property Litigation

Intellectual Property disputes are a complex area of law, often involving deep dives into complex concepts to understand the issues at play. In the United States, the United States Patent and Trademark Office (USPTO/PTO) is the agency involved in registering patents and trademarks.   As part of the USPTO, the Patent Trial and Appeal Board settles patent disputes, using a variety of mechanisms to settle issues related to intellectual property.    Some of the mechanisms include inter partes review, post-grant procedures, and covered business method patent reviews.  Issues related to the America Invents Act are also settled through the PTAB. The National Law Review covers changes to standards held by the USPTO in litigation and other patent issues.  The Trademark Trial and Appeal Board settles disputes related to trademarks, such as an ex parte appeal from the denial of an application for registration by an examining attorney, and an inter partes opposition, cancellation, concurrent use, or interference proceeding.  Other agencies involved in patent disputes are the International Trade Commission (ITC) or the Federal Trade Commission (FTC).  The National Law Review covers patent news as it relates to Supreme Court (SCOTUS) and federal circuit courts’ appeals, as well as general patent litigation and new patent filings.

Intellectual Property in Drug Patents

Legal analysis related to drug patents and pharmaceuticals and the interplay with intellectual property issues are also covered by the National Law Review.   Drug patents, biosimilars, generic top-level domain registration (gTLD), trade secrets, non-compete clauses, and other patent application news are updated on the site regularly. Additionally, tangential issues that impact pharmaceutical companies, such as innovator liability and related litigation, are also analyzed by the legal experts who write for the National Law Review. 

Intellectual Property in an Employment Context

The National Law Review has legal analysis on the intersection between intellectual property rights and employment, and who owns ideas, the Work Made For Hire principle as well resulting litigation. Additionally, legislation such as the Defense of Trade Secrets Act and its impact on workplaces, and ongoing litigation related to the legislation is also covered.

International Intellectual Property

Visitors to the site will oftentimes read about international news as it relates to patent applications in the US, and internationally as well. Pharmaceutical patents in Brazil, medical device patent applications from the United Kingdom, or litigation from the European Union, China, India, and other international sectors, are often covered online. Visitors will find the latest coverage, news, and insights on patent applications and litigation, when visiting the National Law Review, for up-to-date practice-area news.

National Law Review Intellectual Property/Patent Law TwitterFor hourly updates on the latest news about Intellectual Property Law, IP Litigation, Patent Legislation, and more, be sure to follow our IP Law Twitter feed, and sign up for complimentary e-news bulletins.

Recent Intellectual Property, Patent, Trademark & Copyright News

Title
Custom text Organization Sort descending
Jul
18
2022
Strategic IP for Protection of Product Manufacturers Foley & Lardner LLP
Aug
8
2022
USPTO Underscores Duty of Disclosure Pertaining To FDA Submissions Foley & Lardner LLP
Aug
22
2022
Building A Technological Moat: Strategic Use of Continuing Patent Applications Foley & Lardner LLP
Aug
5
2015
Does Spike In IPR Settlements Signify Petitioner Success? Foley & Lardner LLP
Oct
18
2022
Federal Circuit Clarifies Conditions for Standard Essential Patents in LTE Technologies Foley & Lardner LLP
Sep
10
2015
Clinical Trials As Prior Art: PTAB Denies Bass IPR Petition With Only A "Hope" of Efficacy Foley & Lardner LLP
Sep
28
2015
PTAB Refuses To Sanction Kyle Bass Foley & Lardner LLP
Jan
30
2023
Singapore: A Rising Tiger Economy for Startups and Venture Capital in Asia Foley & Lardner LLP
Jun
11
2018
USPTO Vanda Memo Emphasizes Patent Eligibility Of Method Of Treatment Claims Foley & Lardner LLP
Oct
27
2015
Morsa II: Admissions Enable Prior Art Foley & Lardner LLP
Nov
19
2015
Federal Circuit Interprets Two Important Infringement Provisions Foley & Lardner LLP
May
15
2023
No Non-Competes for Lawyers? Trade Secret Misappropriation Lawsuits against Big Law Lawyers and Firm Management on the Rise Foley & Lardner LLP
Dec
3
2015
Federal Circuit Confirms Constitutionality of IPR Proceedings in MCM Portfolio v. Hewlett-Packard Foley & Lardner LLP
Dec
8
2015
Judge Lourie (Federal Circuit) Suggests Jepson Claims For Patent Eligibility Foley & Lardner LLP
Nov
8
2018
PTAB Boardside Chat Provides Further Details About New Amendment Procedure Foley & Lardner LLP
Dec
4
2018
Will PTAB SOP 2 Promote Uniformity Across The USPTO Foley & Lardner LLP
Dec
18
2018
Federal Circuit Says No OTDP Between Novartis Patents That Straddle URAA Foley & Lardner LLP
Jul
6
2023
IP Considerations in Protecting Autonomous Vehicle Software with Patents and Copyrights Foley & Lardner LLP
Feb
16
2019
New Estoppel Concern For Petitioners Raised in BTG v. Amneal Foley & Lardner LLP
Jul
25
2023
Would The Patent Eligibility Restoration Act Strike The Right Balance? Foley & Lardner LLP
Mar
13
2019
Court Dismisses Biosimilar Petitioner's IPR Appeal For Lack of Standing Foley & Lardner LLP
Sep
13
2023
Regulating Influencer Marketing: A Comparative Analysis of Laws Across the World Foley & Lardner LLP
May
30
2019
They Started It! Foley & Lardner LLP
Jun
4
2019
Federal Circuit Invalidates Vimovo Patents Questioning Possession Of Efficacy Under The Written Description Requirement Foley & Lardner LLP
Jun
18
2019
Why The TERM Act Is A Misguided Solution To A Different Problem Foley & Lardner LLP
Jul
23
2019
Australia Holds The Line On Patent Eligibility Of Diagnostic Methods Foley & Lardner LLP
Aug
6
2019
USPTO Proposes Fee Hikes And New Fees Foley & Lardner LLP
Apr
28
2016
Having A Bad Hair Day? The Federal Circuit Agrees That Method Of Cutting Hair Is Invalid Under 101 Foley & Lardner LLP
 

NLR Logo

We collaborate with the world's leading lawyers to deliver news tailored for you. Sign Up to receive our free e-Newsbulletins

 

Sign Up for e-NewsBulletins